Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Window-of-opportunity progesterone study in premenopausal ER-positive, PgR-positive early breast cancer
2017-001521-41Phase 2Unknown
- Sponsor
- University of Liverpool
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of progesterone in breast cancer (2 arms), sponsored by University of Liverpool. Primary endpoint: Ki67 proliferation index. Status: unknown.
02
Drugs
progesterone
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2017-001521-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001521-41.